ID   CARM1_HUMAN             Reviewed;         608 AA.
AC   Q86X55; A6NN38;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=Histone-arginine methyltransferase CARM1;
DE            EC=2.1.1.319 {ECO:0000269|PubMed:19405910};
DE   AltName: Full=Coactivator-associated arginine methyltransferase 1;
DE   AltName: Full=Protein arginine N-methyltransferase 4;
GN   Name=CARM1; Synonyms=PRMT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE [MRNA]
RP   OF 194-608 (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 43-608 (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   METHYLATION OF ELAVL1.
RX   PubMed=12237300; DOI=10.1074/jbc.M206187200;
RA   Li H., Park S., Kilburn B., Jelinek M.A., Henschen-Edman A.,
RA   Aswad D.W., Stallcup M.R., Laird-Offringa I.A.;
RT   "Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing
RT   protein, by CARM1. Coactivator-associated arginine
RT   methyltransferase.";
RL   J. Biol. Chem. 277:44623-44630(2002).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15221992; DOI=10.1002/cncr.20327;
RA   Hong H., Kao C., Jeng M.-H., Eble J.N., Koch M.O., Gardner T.A.,
RA   Zhang S., Li L., Pan C.-X., Hu Z., MacLennan G.T., Cheng L.;
RT   "Aberrant expression of CARM1, a transcriptional coactivator of
RT   androgen receptor, in the development of prostate carcinoma and
RT   androgen-independent status.";
RL   Cancer 101:83-89(2004).
RN   [7]
RP   INTERACTION WITH NR1H4.
RX   PubMed=15471871; DOI=10.1074/jbc.M410021200;
RA   Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J.,
RA   Walsh M.J.;
RT   "Ligand-dependent activation of the farnesoid X-receptor directs
RT   arginine methylation of histone H3 by CARM1.";
RL   J. Biol. Chem. 279:54348-54357(2004).
RN   [8]
RP   METHYLATION OF EP300.
RX   PubMed=15731352; DOI=10.1073/pnas.0407159102;
RA   Lee Y.-H., Coonrod S.A., Kraus W.L., Jelinek M.A., Stallcup M.R.;
RT   "Regulation of coactivator complex assembly and function by protein
RT   arginine methylation and demethylimination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:3611-3616(2005).
RN   [9]
RP   INTERACTION WITH HTLV-1 TAX-1.
RX   PubMed=17005681; DOI=10.1128/JVI.00186-06;
RA   Jeong S.J., Lu H., Cho W.K., Park H.U., Pise-Masison C., Brady J.N.;
RT   "Coactivator-associated arginine methyltransferase 1 enhances
RT   transcriptional activity of the human T-cell lymphotropic virus type 1
RT   long terminal repeat through direct interaction with Tax.";
RL   J. Virol. 80:10036-10044(2006).
RN   [10]
RP   METHYLATION OF HISTONE H3, INTERACTION WITH RELA, AND FUNCTION.
RX   PubMed=16497732; DOI=10.1210/me.2005-0365;
RA   Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
RT   "Coactivator-associated arginine methyltransferase-1 enhances nuclear
RT   factor-kappaB-mediated gene transcription through methylation of
RT   histone H3 at arginine 17.";
RL   Mol. Endocrinol. 20:1562-1573(2006).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=19405910; DOI=10.1042/BJ20090268;
RA   Lakowski T.M., Frankel A.;
RT   "Kinetic analysis of human protein arginine N-methyltransferase 2:
RT   formation of monomethyl- and asymmetric dimethyl-arginine residues on
RT   histone H4.";
RL   Biochem. J. 421:253-261(2009).
RN   [13]
RP   PHOSPHORYLATION AT SER-216, SUBCELLULAR LOCATION, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=19843527; DOI=10.1074/jbc.M109.065524;
RA   Feng Q., He B., Jung S.Y., Song Y., Qin J., Tsai S.Y., Tsai M.J.,
RA   O'Malley B.W.;
RT   "Biochemical control of CARM1 enzymatic activity by phosphorylation.";
RL   J. Biol. Chem. 284:36167-36174(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 135-482 IN COMPLEX WITH SAM
RP   ANALOG AND INHIBITORS, AND SAM BINDING SITES.
RX   PubMed=21410432; DOI=10.1042/BJ20102161;
RA   Sack J.S., Thieffine S., Bandiera T., Fasolini M., Duke G.J.,
RA   Jayaraman L., Kish K.F., Klei H.E., Purandare A.V., Rosettani P.,
RA   Troiani S., Xie D., Bertrand J.A.;
RT   "Structural basis for CARM1 inhibition by indole and pyrazole
RT   inhibitors.";
RL   Biochem. J. 436:331-339(2011).
CC   -!- FUNCTION: Methylates (mono- and asymmetric dimethylation) the
CC       guanidino nitrogens of arginyl residues in several proteins
CC       involved in DNA packaging, transcription regulation, pre-mRNA
CC       splicing, and mRNA stability. Recruited to promoters upon gene
CC       activation together with histone acetyltransferases from
CC       EP300/P300 and p160 families, methylates histone H3 at 'Arg-17'
CC       (H3R17me), forming mainly asymmetric dimethylarginine (H3R17me2a),
CC       leading to activate transcription via chromatin remodeling. During
CC       nuclear hormone receptor activation and TCF7L2/TCF4 activation,
CC       acts synergically with EP300/P300 and either one of the p160
CC       histone acetyltransferases NCOA1/SRC1, NCOA2/GRIP1 and NCOA3/ACTR
CC       or CTNNB1/beta-catenin to activate transcription. During myogenic
CC       transcriptional activation, acts together with NCOA3/ACTR as a
CC       coactivator for MEF2C. During monocyte inflammatory stimulation,
CC       acts together with EP300/P300 as a coactivator for NF-kappa-B.
CC       Acts as coactivator for PPARG, promotes adipocyte differentiation
CC       and the accumulation of brown fat tissue. Plays a role in the
CC       regulation of pre-mRNA alternative splicing by methylation of
CC       splicing factors. Also seems to be involved in p53/TP53
CC       transcriptional activation. Methylates EP300/P300, both at 'Arg-
CC       2142', which may loosen its interaction with NCOA2/GRIP1, and at
CC       'Arg-580' and 'Arg-604' in the KIX domain, which impairs its
CC       interaction with CREB and inhibits CREB-dependent transcriptional
CC       activation. Also methylates arginine residues in RNA-binding
CC       proteins PABPC1, ELAVL1 and ELAV4, which may affect their mRNA-
CC       stabilizing properties and the half-life of their target mRNAs.
CC       {ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:19405910}.
CC   -!- CATALYTIC ACTIVITY: 2 S-adenosyl-L-methionine + [protein]-L-
CC       arginine = 2 S-adenosyl-L-homocysteine + [protein]-
CC       N(omega),N(omega)-dimethyl-L-arginine.
CC       {ECO:0000269|PubMed:19405910}.
CC   -!- ENZYME REGULATION: Methylation of H3R17 (H3R17me) by CARM1 is
CC       stimulated by preacetylation of H3 'Lys-18' (H3K18ac) H3 'Lys-23'
CC       (H3K23ac) by EP300 and blocked by citrullination of H3 'Arg-17'
CC       (H3R17ci) by PADI4. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer (Probable). Interacts with the C-terminus of
CC       NCOA2/GRIP1, NCO3/ACTR and NCOA1/SRC1. Part of a complex
CC       consisting of CARM1, EP300/P300 and NCOA2/GRIP1. Interacts with
CC       FLII, TP53, myogenic factor MEF2, EP300/P300, TRIM24, CREBBP and
CC       CTNNB1. Identified in a complex containing CARM1, TRIM24 and
CC       NCOA2/GRIP1. Interacts with NCOA3/SRC3. Interacts with SNRPC (By
CC       similarity). Interacts with NR1H4. Interacts with RELA. Interacts
CC       with HTLV-1 Tax-1. {ECO:0000250, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17005681,
CC       ECO:0000269|PubMed:21410432, ECO:0000305}.
CC   -!- INTERACTION:
CC       P17676:CEBPB; NbExp=2; IntAct=EBI-2339854, EBI-969696;
CC       Q05826:CEBPB (xeno); NbExp=3; IntAct=EBI-2339854, EBI-7774198;
CC       Q96EY1:DNAJA3; NbExp=2; IntAct=EBI-2339854, EBI-356767;
CC       Q9Y6Q9:NCOA3; NbExp=12; IntAct=EBI-2339854, EBI-81196;
CC       O43809:NUDT21; NbExp=2; IntAct=EBI-2339854, EBI-355720;
CC       Q96PU8:QKI; NbExp=2; IntAct=EBI-2339854, EBI-945792;
CC       Q92922:SMARCC1; NbExp=4; IntAct=EBI-2339854, EBI-355653;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Mainly nuclear
CC       during the G1, S and G2 phases of the cell cycle. Cytoplasmic
CC       during mitosis, after breakup of the nuclear membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=Q86X55-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q86X55-1; Sequence=VSP_039876;
CC       Name=2;
CC         IsoId=Q86X55-2; Sequence=VSP_012506, VSP_012507;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Overexpressed in prostate adenocarcinomas and
CC       high-grade prostatic intraepithelial neoplasia.
CC       {ECO:0000269|PubMed:15221992}.
CC   -!- PTM: Auto-methylated on Arg-550. Methylation enhances
CC       transcription coactivator activity. Methylation is required for
CC       its role in the regulation of pre-mRNA alternative splicing (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Ser-216 interferes with S-adenosyl-L-
CC       methionine binding and strongly reduces methyltransferase activity
CC       (By similarity). Phosphorylation at Ser-216 is strongly increased
CC       during mitosis, and decreases rapidly to a very low, basal level
CC       after entry into the G1 phase of the cell cycle. Phosphorylation
CC       at Ser-216 may promote location in the cytosol. {ECO:0000250,
CC       ECO:0000269|PubMed:19843527}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding
CC       methyltransferase superfamily. Protein arginine N-
CC       methyltransferase family. {ECO:0000255|PROSITE-ProRule:PRU01015}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011442; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84156.1; -; Genomic_DNA.
DR   EMBL; BC046240; AAH46240.1; -; mRNA.
DR   EMBL; BC172490; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL833242; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS12250.1; -. [Q86X55-3]
DR   RefSeq; NP_954592.1; NM_199141.1. [Q86X55-3]
DR   RefSeq; XP_005259765.1; XM_005259708.4. [Q86X55-1]
DR   UniGene; Hs.323213; -.
DR   PDB; 2Y1W; X-ray; 2.10 A; A/B/C/D=135-482.
DR   PDB; 2Y1X; X-ray; 2.40 A; A/B/C/D=135-482.
DR   PDB; 4IKP; X-ray; 2.00 A; A/B/C/D=140-480.
DR   PDB; 5DWQ; X-ray; 2.36 A; A/B/C/D=134-479.
DR   PDB; 5DX0; X-ray; 2.05 A; A/B/C/D=134-479.
DR   PDB; 5DX1; X-ray; 1.93 A; A/B/C/D=134-479.
DR   PDB; 5DX8; X-ray; 1.94 A; A/B/C/D=134-479.
DR   PDB; 5DXA; X-ray; 2.07 A; A/B/C/D=134-479.
DR   PDB; 5DXJ; X-ray; 1.95 A; A/B/C/D=134-479.
DR   PDB; 5U4X; X-ray; 1.88 A; A/B/C/D=140-480.
DR   PDBsum; 2Y1W; -.
DR   PDBsum; 2Y1X; -.
DR   PDBsum; 4IKP; -.
DR   PDBsum; 5DWQ; -.
DR   PDBsum; 5DX0; -.
DR   PDBsum; 5DX1; -.
DR   PDBsum; 5DX8; -.
DR   PDBsum; 5DXA; -.
DR   PDBsum; 5DXJ; -.
DR   PDBsum; 5U4X; -.
DR   ProteinModelPortal; Q86X55; -.
DR   SMR; Q86X55; -.
DR   BioGrid; 115760; 112.
DR   DIP; DIP-44071N; -.
DR   IntAct; Q86X55; 33.
DR   MINT; MINT-3379851; -.
DR   STRING; 9606.ENSP00000325690; -.
DR   BindingDB; Q86X55; -.
DR   ChEMBL; CHEMBL5406; -.
DR   GuidetoPHARMACOLOGY; 1255; -.
DR   iPTMnet; Q86X55; -.
DR   PhosphoSitePlus; Q86X55; -.
DR   BioMuta; CARM1; -.
DR   DMDM; 308153622; -.
DR   EPD; Q86X55; -.
DR   PaxDb; Q86X55; -.
DR   PeptideAtlas; Q86X55; -.
DR   PRIDE; Q86X55; -.
DR   DNASU; 10498; -.
DR   Ensembl; ENST00000327064; ENSP00000325690; ENSG00000142453. [Q86X55-3]
DR   Ensembl; ENST00000344150; ENSP00000340934; ENSG00000142453. [Q86X55-1]
DR   GeneID; 10498; -.
DR   KEGG; hsa:10498; -.
DR   UCSC; uc002mpz.4; human. [Q86X55-3]
DR   CTD; 10498; -.
DR   DisGeNET; 10498; -.
DR   GeneCards; CARM1; -.
DR   H-InvDB; HIX0014757; -.
DR   HGNC; HGNC:23393; CARM1.
DR   HPA; CAB032961; -.
DR   HPA; HPA043561; -.
DR   HPA; HPA048073; -.
DR   MIM; 603934; gene.
DR   neXtProt; NX_Q86X55; -.
DR   OpenTargets; ENSG00000142453; -.
DR   PharmGKB; PA134959553; -.
DR   eggNOG; KOG1500; Eukaryota.
DR   eggNOG; ENOG410XPDD; LUCA.
DR   GeneTree; ENSGT00550000074406; -.
DR   HOGENOM; HOG000198522; -.
DR   HOVERGEN; HBG050797; -.
DR   InParanoid; Q86X55; -.
DR   KO; K05931; -.
DR   OMA; CNSVLLQ; -.
DR   OrthoDB; EOG091G04X2; -.
DR   PhylomeDB; Q86X55; -.
DR   TreeFam; TF323332; -.
DR   BRENDA; 2.1.1.125; 2681.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha).
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   SIGNOR; Q86X55; -.
DR   ChiTaRS; CARM1; human.
DR   GenomeRNAi; 10498; -.
DR   PRO; PR:Q86X55; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000142453; -.
DR   CleanEx; HS_CARM1; -.
DR   ExpressionAtlas; Q86X55; baseline and differential.
DR   Genevisible; Q86X55; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IEA:Ensembl.
DR   GO; GO:0008013; F:beta-catenin binding; TAS:AgBase.
DR   GO; GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0035642; F:histone methyltransferase activity (H3-R17 specific); ISS:UniProtKB.
DR   GO; GO:0008469; F:histone-arginine N-methyltransferase activity; IDA:CACAO.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0008276; F:protein methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0016274; F:protein-arginine N-methyltransferase activity; IDA:MGI.
DR   GO; GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0060350; P:endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0034971; P:histone H3-R17 methylation; ISS:UniProtKB.
DR   GO; GO:0034970; P:histone H3-R2 methylation; IMP:UniProtKB.
DR   GO; GO:0016571; P:histone methylation; IDA:UniProtKB.
DR   GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:2000171; P:negative regulation of dendrite development; IEA:Ensembl.
DR   GO; GO:0032091; P:negative regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
DR   GO; GO:0071168; P:protein localization to chromatin; IEA:Ensembl.
DR   GO; GO:0003420; P:regulation of growth plate cartilage chondrocyte proliferation; IEA:Ensembl.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902415; P:regulation of mRNA binding; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR025799; Arg_MeTrfase.
DR   InterPro; IPR020989; Histone-Arg_MeTrfase_N.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   Pfam; PF11531; CARM1; 1.
DR   Pfam; PF05185; PRMT5; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51678; SAM_MT_PRMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Host-virus interaction; Methylation;
KW   Methyltransferase; Nucleus; Phosphoprotein; Reference proteome;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    608       Histone-arginine methyltransferase CARM1.
FT                                /FTId=PRO_0000212338.
FT   DOMAIN      146    453       SAM-dependent MTase PRMT-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01015}.
FT   REGION      499    608       Transactivation domain. {ECO:0000250}.
FT   BINDING     159    159       S-adenosyl-L-methionine.
FT   BINDING     168    168       S-adenosyl-L-methionine.
FT   BINDING     192    192       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen.
FT   BINDING     214    214       S-adenosyl-L-methionine.
FT   BINDING     243    243       S-adenosyl-L-methionine.
FT   BINDING     271    271       S-adenosyl-L-methionine.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES     216    216       Phosphoserine.
FT                                {ECO:0000269|PubMed:19843527}.
FT   MOD_RES     550    550       Dimethylated arginine.
FT                                {ECO:0000250|UniProtKB:Q9WVG6}.
FT   VAR_SEQ     369    384       RIEIPFKFHMLHSGLV -> SACLASPAATALCLPG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012506.
FT   VAR_SEQ     385    608       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012507.
FT   VAR_SEQ     539    561       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039876.
FT   HELIX       136    140       {ECO:0000244|PDB:5DX1}.
FT   HELIX       147    153       {ECO:0000244|PDB:5U4X}.
FT   HELIX       156    163       {ECO:0000244|PDB:5U4X}.
FT   HELIX       166    178       {ECO:0000244|PDB:5U4X}.
FT   HELIX       180    182       {ECO:0000244|PDB:5U4X}.
FT   TURN        183    185       {ECO:0000244|PDB:5U4X}.
FT   STRAND      187    192       {ECO:0000244|PDB:5U4X}.
FT   HELIX       197    204       {ECO:0000244|PDB:5U4X}.
FT   STRAND      208    214       {ECO:0000244|PDB:5U4X}.
FT   HELIX       218    228       {ECO:0000244|PDB:5U4X}.
FT   TURN        232    234       {ECO:0000244|PDB:5U4X}.
FT   STRAND      235    240       {ECO:0000244|PDB:5U4X}.
FT   TURN        242    244       {ECO:0000244|PDB:5U4X}.
FT   STRAND      251    256       {ECO:0000244|PDB:5U4X}.
FT   TURN        264    266       {ECO:0000244|PDB:5U4X}.
FT   HELIX       268    274       {ECO:0000244|PDB:5U4X}.
FT   HELIX       275    278       {ECO:0000244|PDB:5U4X}.
FT   STRAND      279    287       {ECO:0000244|PDB:5U4X}.
FT   STRAND      289    297       {ECO:0000244|PDB:5U4X}.
FT   HELIX       300    310       {ECO:0000244|PDB:5U4X}.
FT   HELIX       311    314       {ECO:0000244|PDB:5U4X}.
FT   HELIX       324    326       {ECO:0000244|PDB:5U4X}.
FT   HELIX       327    335       {ECO:0000244|PDB:5U4X}.
FT   STRAND      339    341       {ECO:0000244|PDB:5U4X}.
FT   HELIX       345    347       {ECO:0000244|PDB:5U4X}.
FT   STRAND      353    358       {ECO:0000244|PDB:5U4X}.
FT   TURN        359    361       {ECO:0000244|PDB:5U4X}.
FT   HELIX       364    368       {ECO:0000244|PDB:5U4X}.
FT   STRAND      369    377       {ECO:0000244|PDB:5U4X}.
FT   STRAND      382    396       {ECO:0000244|PDB:5U4X}.
FT   STRAND      401    405       {ECO:0000244|PDB:5U4X}.
FT   STRAND      417    428       {ECO:0000244|PDB:5U4X}.
FT   STRAND      433    442       {ECO:0000244|PDB:5U4X}.
FT   STRAND      446    456       {ECO:0000244|PDB:5U4X}.
FT   TURN        457    459       {ECO:0000244|PDB:5U4X}.
FT   STRAND      462    468       {ECO:0000244|PDB:5U4X}.
SQ   SEQUENCE   608 AA;  65854 MW;  094AC60D4A70B263 CRC64;
     MAAAAAAVGP GAGGAGSAVP GGAGPCATVS VFPGARLLTI GDANGEIQRH AEQQALRLEV
     RAGPDSAGIA LYSHEDVCVF KCSVSRETEC SRVGKQSFII TLGCNSVLIQ FATPNDFCSF
     YNILKTCRGH TLERSVFSER TEESSAVQYF QFYGYLSQQQ NMMQDYVRTG TYQRAILQNH
     TDFKDKIVLD VGCGSGILSF FAAQAGARKI YAVEASTMAQ HAEVLVKSNN LTDRIVVIPG
     KVEEVSLPEQ VDIIISEPMG YMLFNERMLE SYLHAKKYLK PSGNMFPTIG DVHLAPFTDE
     QLYMEQFTKA NFWYQPSFHG VDLSALRGAA VDEYFRQPVV DTFDIRILMA KSVKYTVNFL
     EAKEGDLHRI EIPFKFHMLH SGLVHGLAFW FDVAFIGSIM TVWLSTAPTE PLTHWYQVRC
     LFQSPLFAKA GDTLSGTCLL IANKRQSYDI SIVAQVDQTG SKSSNLLDLK NPFFRYTGTT
     PSPPPGSHYT SPSENMWNTG STYNLSSGMA VAGMPTAYDL SSVIASGSSV GHNNLIPLAN
     TGIVNHTHSR MGSIMSTGIV QGSSGAQGSG GGSTSAHYAV NSQFTMGGPA ISMASPMSIP
     TNTMHYGS
//
